Paper42579268
Extended Venous Thromboembolism Prophylaxis After One-Anastomosis Gastric Bypass: A Three-Arm Randomized Trial of Enoxaparin Duration and Rivaroxaban.
Nageeb ME and 5 others. Obes Surg, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Extended Venous Thromboembolism Prophylaxis After One-Anastomosis Gastric Bypass: A Three-Arm Randomized Trial of Enoxaparin Duration and Rivaroxaban. Papers, record 42579268. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42579268
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Extended Venous Thromboembolism Prophylaxis After One-Anastomosis Gastric Bypass: A Three-Arm Randomized Trial of Enoxaparin Duration and Rivaroxaban.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enoxaparin | Major topic |
| Rivaroxaban | Major topic |
| Venous Thromboembolism | Major topic |
| Obesity, Morbid | Major topic |
| Anticoagulants | Major topic |
| Gastric Bypass | Major topic |
| Factor Xa Inhibitors | Major topic |
| Postoperative Complications | Major topic |
| Humans | |
| Female | |
| Male | |
| Adult | |
| Middle Aged | |
| Drug Administration Schedule | |
| Treatment Outcome | |
| Laparoscopy |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34860988 | Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue? | J Pharm Technol | 2016 | https://conductscience.org/library/papers/34860988 | PubMed |
| 2 | 11451734 | Mechanism of action and pharmacology of unfractionated heparin. | Arterioscler Thromb Vasc Biol | 2001 | https://conductscience.org/library/papers/11451734 | PubMed |
| 3 | 38602603 | Cumulative Incidence of Venous Thromboembolic Events In-Hospital, and at 1, 3, 6, and 12 Months After Metabolic and Bariatric Surgery: Systematic Review of 87 Studies and Meta-analysis of 2,731,797 Patients. | Obes Surg | 2024 | https://conductscience.org/library/papers/38602603 | PubMed |
| 4 | 35844166 | Direct oral anticoagulants after bariatric surgery-What is the evidence? | J Thromb Haemost | 2022 | https://conductscience.org/library/papers/35844166 | PubMed |
| 5 | 28009739 | Who Should Get Extended Thromboprophylaxis After Bariatric Surgery?: A Risk Assessment Tool to Guide Indications for Post-discharge Pharmacoprophylaxis. | Ann Surg | 2017 | https://conductscience.org/library/papers/28009739 | PubMed |
| 6 | 32969260 | Prophylaxis with rivaroxaban after laparoscopic sleeve gastrectomy could reduce the frequency of portomesenteric venous thrombosis. | Ann R Coll Surg Engl | 2020 | https://conductscience.org/library/papers/32969260 | PubMed |
| 7 | 24022324 | Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study. | Obes Surg | 2013 | https://conductscience.org/library/papers/24022324 | PubMed |
| 8 | 20888031 | The mechanism of action of rivaroxaban--an oral, direct Factor Xa inhibitor--compared with other anticoagulants. | Thromb Res | 2011 | https://conductscience.org/library/papers/20888031 | PubMed |
| 9 | 41226331 | The Interplay Between Obesity and Venous Thromboembolism: From Molecular Aspects to Clinical Issue. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226331 | PubMed |
| 10 | 26713434 | Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England. | PLoS One | 2015 | https://conductscience.org/library/papers/26713434 | PubMed |
| 11 | 26276933 | Postsurgical Inflammation as a Causative Mechanism of Venous Thromboembolism. | Semin Thromb Hemost | 2015 | https://conductscience.org/library/papers/26276933 | PubMed |
| 12 | 40917200 | Obesity and Venous Thromboembolism: Mechanisms, Clinical Implications, and Prevention Strategies With a Focus on Bariatric Surgery. | J Metab Bariatr Surg | 2025 | https://conductscience.org/library/papers/40917200 | PubMed |
| 13 | 35788047 | Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis. | BMJ | 2022 | https://conductscience.org/library/papers/35788047 | PubMed |
| 14 | 35620356 | Role of Direct Oral Anticoagulants for Post-operative Venous Thromboembolism Prophylaxis. | Eur Cardiol | 2022 | https://conductscience.org/library/papers/35620356 | PubMed |
| 15 | 31285809 | Patient compliance with deep vein thrombosis prophylaxis after total hip and total knee arthroplasty. | Hematol Rep | 2019 | https://conductscience.org/library/papers/31285809 | PubMed |
| 16 | 21421182 | Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database. | Surg Obes Relat Dis | 2011 | https://conductscience.org/library/papers/21421182 | PubMed |
| 17 | 28159600 | Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance. | Am J Med | 2017 | https://conductscience.org/library/papers/28159600 | PubMed |
| 18 | 38266535 | Pharmacokinetics of direct oral anticoagulants after bariatric surgery: A retrospective cohort study. | Thromb Res | 2024 | https://conductscience.org/library/papers/38266535 | PubMed |
| 19 | 38957028 | European guidelines on peri-operative venous thromboembolism prophylaxis: first update.: Chapter 10: Surgery in the obese patient. | Eur J Anaesthesiol | 2024 | https://conductscience.org/library/papers/38957028 | PubMed |
| 20 | 37227726 | Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery: A Randomized Clinical Trial. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37227726 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42579268
GET https://conductscience.org/api/papers/v1/42579268/references?page=2